NIMOTOP (nimodipine) is a calcium channel blocker indicated for patients with subarachnoid hemorrhage. It improves neurological outcome by relaxing cerebral smooth muscle vasculature and ...

The injectable formulation of nimodipine is in clinical stages, being developed for IV infusions in patients with aneurysmal subarachnoid haemorrhage (aSAH), a type of stroke caused by the rupture of ...

Grace Therapeutics Inc. (NASDAQ:GRCE), a $32.85 million market cap biotechnology company whose stock has gained over 37% in the past six months, has announced successful outcomes from its Phase 3 ...

KOL Event on aneurysmal Subarachnoid Hemorrhage (aSAH) ...

GRCE READ THE FULL GRCE RESEARCH REPORT Grace Therapeutics, Inc (NASDAQ:GRCE) reported fiscal year (FY) third quarter results following a series of announcements regarding conference participation, ...

Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical Benefit Compared to Orally Administered Nimodipine; New Drug Application (NDA) Submission Anticipated First Half of ...

Discover all the brand names or Trade names of generic drug called Nimodipine. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to ...

Following diagnosis of postpartum cerebral angiopathy on postpartum day 10, nimodipine was initiated to treat the vasospasm, and the headache was treated with opioid analgesics and toradol ...

The STRIVE-ON trial was a prospective, randomized open-label trial of GTx-104 compared with oral nimodipine in patients hospitalized with aSAH. 50 patients were administered GTx-104 and 52 patients ...

GTx-104 reduced clinically significant hypotension by 19% versus oral nimodipine (28% vs. 35%) in aSAH patients. 54% of GTx-104 patients maintained 95%+ relative dose intensity versus 8% on oral ...

The injectable formulation of nimodipine is in clinical stages, being developed for IV infusions in patients with aneurysmal subarachnoid haemorrhage (aSAH), a type of stroke caused by the rupture ...